Sygnis AG reported earnings results for the first quarter ended March 31, 2018. For the quarter, the company reported revenues of EUR 2,309,000 against EUR 1,370,000 a year ago. EBITDA was EUR 50,000 against LBITDA of EUR 605,000 a year ago. Net loss for the period was EUR 322,000 against EUR 1,202,000 a year ago. Revenues increased 69%, primarily attributable to the sale of the company's own kits and devices. Cash outflows from operating activities were EUR 0.4 million compared to EUR 0.8 million a year ago.

For the year 2018, the company expects revenues to be in the range of EUR 11 million to EUR 12 million without considering the impact of TGR Biosciences. This current revenue forecast is based on continued strong organic growth of the product sales in line with the previous year. The management board continues to expect a strong result for 2018 with a positive EBITDA result for the year as well as the group becoming overall cash generative during the course of 2018.